Skip to main content
Veterinary Medicines

Advantage Dog 400 400 mg/4 ml Solution pour application cutanée

Authorised
  • Imidacloprid

Product identification

Medicine name:
Advantage Dog 400 400 mg/4 ml Solution pour application cutanée
Active substance:
  • Imidacloprid
Target species:
  • Dog
Route of administration:
  • Cutaneous use

Product details

Active substance and strength:
  • Imidacloprid
    400.00
    milligram(s)
    /
    4.00
    millilitre(s)
Pharmaceutical form:
  • Cutaneous solution
Withdrawal period by route of administration:
  • Cutaneous use
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP53AX17
Authorisation status:
  • Valid
Authorised in:
  • Luxembourg
Available in:
  • Luxembourg
Package description:
  • Advantage Dog 400 2 4 ml Pipette Cutaneous solution
  • Advantage Dog 400 3 4 ml Pipette Cutaneous solution
  • Advantage Dog 400 4 4 ml Pipette Cutaneous solution
  • Advantage Dog 400 6 4 ml Pipette Cutaneous solution

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Elanco Animal Health GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • KVP Pharma+Veterinär Produkte GmbH
Responsible authority:
  • Ministere De La Sante Division De La Pharmacie Et Des Medicaments
Authorisation number:
  • V 442/14/03/1357
Date of authorisation status change:
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."